US Patent and Trademark Office Impersonator Reported to FTC
MADISON, CONN. Feb. 11, 2026 – A company calling itself “Patent & Trademark Office” is violating the FTC’s Impersonation Rule as well as the FTC Act by falsely posing as…
In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)
MADISON, CONN. Feb. 11, 2026 – A company calling itself “Patent & Trademark Office” is violating the FTC’s Impersonation Rule as well as the FTC Act by falsely posing as…
Complaint to FTC cites violations of agency’s Impersonation Rule.
TINA.org digs into shop’s purported Newport roots, and more.
TINA.org staffer gets surprise charge.
TINA.org files complaint with NYC over company’s “$19.95” truck rentals.